Latest news with #novavax.com
Yahoo
07-05-2025
- Business
- Yahoo
Novavax to Participate in BofA Securities 2025 Health Care Conference
GAITHERSBURG, Md., May 7, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the BofA Securities 2025 Health Care Conference. Conference Details: Fireside Chat Date: Wednesday, May 14, 2025 Time: 3:00 – 3:30 p.m. Pacific Time (PT) Location: Las Vegas, NV Conference Event: Investor Meetings Date: Wednesday, May 14, 2025 A webcast of the fireside chat will be available on the Events & Presentations page of the Company's website at A replay of the webcast will be available for 30 days. About Novavax Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most significant health challenges by leveraging its scientific expertise in vaccines and its cutting-edge technology platform, which includes protein-based nanoparticles and its Matrix-M® adjuvant. The Company's growth strategy is focused on building new and diversified partnerships via the out-licensing of its technology platform and vaccine assets earlier in the development process. These strategic collaborations are fueled by smart investments in a growing early-stage pipeline starting with the Company's core expertise in infectious disease and potentially expanding into other disease areas. Please visit and LinkedIn for more information. Contacts: Investors Luis Sanay, CFA 240-268-2022 ir@ Media Giovanna Chandler 202-709-5563 media@ Novavax Logo (PRNewsfoto/Novavax) Cision View original content to download multimedia: SOURCE Novavax, Inc.
Yahoo
01-05-2025
- Business
- Yahoo
Novavax to Report First Quarter 2025 Financial Results on May 8, 2025
GAITHERSBURG, Md., May 1, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will report its first quarter 2025 financial results and operational highlights at 8:30 a.m. Eastern Time (ET) on Thursday, May 8, 2025. Details of the event and replay are as follows: Conference call details:Date: May 8, 2025 Time: 8:30 a.m. U.S. ET URL to register phone: Dial-in number: (800) 836-8184 (Domestic) or(+1) (646) 357-8785 (International) Webcast: Participants can join the conference call without operator assistance by registering and entering their phone number with the above URL to receive an instant automated call back. Participants can also dial direct to be entered into the call by an operator and will be prompted to request to join the Novavax, Inc. call. To ensure a timely connection, it is recommended that participants join at least 10 minutes prior to the scheduled start time. Replay details:Date: Available starting at 11:30 a.m. U.S. ET, May 8, 2025, until 11:59 p.m. U.S. ET, May 15, 2025 Dial-in number: (888) 660-6345 (Domestic) or(+1) (646) 517-4150 (International) Passcode: 88407# Webcast: until June 7, 2025 About NovavaxNovavax, Inc. (Nasdaq: NVAX) tackles some of the world's most significant health challenges by leveraging its scientific expertise in vaccines and its cutting-edge technology platform, which includes protein-based nanoparticles and its Matrix-M® adjuvant. The Company's growth strategy is focused on building new and diversified partnerships via the out-licensing of its technology platform and vaccine assets earlier in the development process. These strategic collaborations are fueled by smart investments in a growing early-stage pipeline starting with the Company's core expertise in infectious disease and potentially expanding into other disease areas. Please visit and LinkedIn for more information. Contacts: Investors Luis Sanay, CFA240-268-2022ir@ MediaGiovanna Chandler202-709-5563media@ View original content to download multimedia: SOURCE Novavax, Inc. Sign in to access your portfolio
Yahoo
27-02-2025
- Business
- Yahoo
Novavax to Participate in Upcoming March Investor Conferences
GAITHERSBURG, Md., Feb. 27, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), today announced that the management team will participate in the following upcoming investor conferences: TD Cowen 45th Annual Health Care Conference: Fireside Chat Date: Tuesday, March 4, 2025Time: 9:10 – 9:40 a.m. Eastern Time (ET)Location: Boston, MA Conference Event: Investor MeetingsDate: Tuesday, March 4, 2025 Leerink Partners 2025 Global Healthcare Conference: Presentation Date: Tuesday, March 11, 2025Time: 3:40 – 4:10 p.m. ETLocation: Miami Beach, FL Conference Event: Investor MeetingsDate: Tuesday, March 11, 2025 Jefferies Biotech on the Beach Summit: Conference Event: Investor MeetingsDate: Wednesday, March 12, 2025Location: Miami Beach, FL A webcast of the fireside chat and presentation will be available through the Events and Presentations page of the Company's website at with replays available for 30 days after the conferences. About Novavax Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most significant health challenges by leveraging its scientific expertise in vaccines and its cutting-edge technology platform, including a protein-based nanoparticle and Matrix-M™ adjuvant. The Company's growth strategy is focused on building new and diversified partnerships via the out-licensing of its technology platform and vaccine assets earlier in the development process. These strategic collaborations are fueled by smart investments in a growing early-stage pipeline starting with the Company's core expertise in infectious disease and potentially expanding into other disease areas. Please visit and LinkedIn for more information. Contacts:InvestorsLuis Sanay, CFA240-268-2022ir@ MediaGiovanna Chandler202-709-5563media@ View original content to download multimedia: SOURCE Novavax, Inc.
Yahoo
20-02-2025
- Business
- Yahoo
Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights on February 27, 2025
GAITHERSBURG, Md., Feb. 20, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will report its fourth quarter and full year 2024 financial results and operational highlights at 8:30 a.m. Eastern Time (ET) on Thursday, February 27, 2025. Details of the event and replay are as follows: Conference call details:Date: February 27, 2025 Time: 8:30 a.m. U.S. ET URL to register phone: Dial-in number: (800) 836-8184 (Domestic) or(+1) (646) 357-8785 (International) Webcast: Participants can join the conference call without operator assistance by registering and entering their phone number with the above URL to receive an instant automated call back. Participants can also dial direct to be entered into the call by an operator and will be prompted to request to join the Novavax, Inc. call. To ensure a timely connection, it is recommended that participants join at least 10 minutes prior to the scheduled webcast. Replay details:Date: Available starting at 11:30 a.m. U.S. ET, February 27, 2025, until 11:59 p.m. U.S. ET, March 6, 2025 Dial-in number: (888) 660-6345 (Domestic) or(+1) (646) 517-4150 (International) Passcode: 79349# Webcast: until March 29, 2025 About NovavaxNovavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to help protect against serious infectious diseases. Novavax, a global company based in Gaithersburg, Md., U.S., offers a differentiated vaccine platform that combines a recombinant protein approach, innovative nanoparticle technology and Novavax's patented Matrix-M adjuvant to enhance the immune response. The Company's portfolio includes its COVID-19 vaccine and its pipeline includes COVID-19-Influenza Combination and stand-alone influenza vaccine candidates. In addition, Novavax's adjuvant is included in the University of Oxford and Serum Institute of India's R21/Matrix-M malaria vaccine. Please visit and LinkedIn for more information. Contacts: InvestorsLuis Sanay, CFA240-268-2022ir@ MediaGiovanna Chandler202-709-5563media@ View original content to download multimedia: SOURCE Novavax, Inc. Sign in to access your portfolio
